Global Market Size, Forecast, and Trend Highlights Over 2025-2037
DiGeorge Syndrome Drug Market size is set to register remarkable growth rate during the forecast period i.e., between 2025-2037.
The market growth is driven by the growing patient pool of the disease and the need for treatment for the wide range of symptoms caused by this genetic disorder. The symptoms of this disorder include congenital heart disease, cleft palate, learning and development delay, and mental disorders including autism spectrum disorder (ASD), anxiety disorder, and psychotic disorders, such as, schizophrenia among others. These symptoms may vary from person to person, which induces the need for a different and specific treatment approach for every individual. This, in turn, is estimated to boost the market growth by the end of 2029. Moreover, the cause of deletion of chromosome 22 is still unknown, creating vast scope for research activities in this direction, which is estimated to generate immense opportunity for the market growth throughout the forecast period.
